COMMUNIQUÉS West-GlobeNewswire

Progressive Care Reports Strong November Sales to Begin End of Year Rally
15/12/2017
MIAMI, Dec. 15, 2017 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB:RXMD), through its subsidiaries Smart Medical Alliance, Inc. and PharmCo, LLC, is a South Florida health services organization and provider of [...]
Ultragenyx and Kyowa Kirin Announce Burosumab Receives Positive CHMP Opinion for the Treatment of X-Linked Hypophosphatemia in Children
15/12/2017
TOKYO, LONDON and NOVATO, Calif., Dec. 15, 2017 (GLOBE NEWSWIRE) -- Kyowa Hakko Kirin Co., Ltd. (Kyowa Hakko Kirin), Kyowa Kirin International PLC (Kyowa Kirin International) and Ultragenyx Pharmaceutical Inc. (NASDAQ: [...]
Northern Vine Labs Expands Dealer’s License with Health Canada
15/12/2017
VICTORIA, B.C., Dec. 15, 2017 (GLOBE NEWSWIRE) -- Northern Vine Labs (“Company”), a subsidiary of Emerald Health Therapeutics Inc. (“Emerald”) (TSXV:EMH) (OTCQX:EMHTF) and Abattis Bioceuticals Corp. (“Abattis”) (CSE:ATT [...]
Mersana Therapeutics Added to NASDAQ Biotechnology Index
15/12/2017
CAMBRIDGE, Mass., Dec. 15, 2017 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc., (NASDAQ: MRSN ) a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates ( [...]
PolarityTE™ Announces Application of SkinTE™ on First Patients
15/12/2017
SALT LAKE CITY, Dec. 15, 2017 (GLOBE NEWSWIRE) -- PolarityTE, Inc. (NASDAQ: COOL ) announced that human use of SkinTE™ is underway, and the product is now on patients, at multiple centers, within a variety of wound [...]
Tetraphase Pharmaceuticals Added to NASDAQ Biotechnology Index
15/12/2017
WATERTOWN, Mass., Dec. 15, 2017 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ: TTPH ), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening multidrug-resistant [...]
IBEX Reports First Quarter Fiscal 2018 Results
15/12/2017
MONTREAL, Dec. 15, 2017 (GLOBE NEWSWIRE) -- IBEX Technologies Inc. (“IBEX” or the “Company”) (TSX Venture:IBT) today reported its financial results for the quarter ended October 31, 2017. “Revenues and earnings for the [...]
Surgery Partners, Inc. Announces $50.0 Million Share Repurchase Program
15/12/2017
BRENTWOOD, Tenn., Dec. 15, 2017 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ: SGRY ) ("Surgery Partners" or the "Company"), a leading provider of surgical services, today announced that its Board of Directors has [...]
Extendicare Announces December 2017 Dividend of C$0.04 per Share
15/12/2017
MARKHAM, Ontario, Dec. 15, 2017 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE ) announced that it has declared a cash dividend of C$0.04 per common share of the Company (the “Common [...]
American Health Council Names Leslie Fletcher, BSN, RN, MEP-C to Nursing Board
15/12/2017
NEW YORK, Dec. 15, 2017 (GLOBE NEWSWIRE) -- The American Health Council has selected Leslie Fletcher, BSN, RN, MEP-C to join the Nursing Board. She has been chosen due to her impeccable work in the field of Aesthetics. [...]
Athenex Announces Initiation of an Oral Eribulin Investigational New Drug Development Program for Oncology Indications
15/12/2017
Athenex has developed a novel synthetic method for Eribulin with an excellent purity profile Athenex has developed an oral version of Eribulin based on the Orascovery program which showed good oral absorption in [...]
Endocyte Added to NASDAQ Biotechnology Index
15/12/2017
WEST LAFAYETTE, Ind., Dec. 15, 2017 (GLOBE NEWSWIRE) -- Endocyte, Inc. (NASDAQ: ECYT ), a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment, today announced that it has been [...]
Ozempic® (semaglutide) recommended for approval by the European regulatory authorities
15/12/2017
Bagsværd, Denmark, 15 December 2017 - Novo Nordisk today announced that the Committee for Medicinal Products for Human Use (CHMP) under the European Medicines Agency (EMA) has adopted a positive opinion, recommending [...]
Takeda and TiGenix announce that Cx601 (darvadstrocel) has received a positive CHMP opinion to treat complex perianal fistulas in Crohn's disease
15/12/2017
PRESS RELEASE REGULATED INFORMATION INSIDE INFORMATION Takeda and TiGenix announce that Cx601 (darvadstrocel) has received a positive CHMP opinion to treat complex perianal fistulas in Crohn's disease First allogeneic [...]
Takeda et TiGenix annoncent que le Cx601 (darvadstrocel) a reçu la décision favorable du CHMP dans le traitement des fistules périanales complexes de la maladie de Crohn
15/12/2017
COMMUNIQUE DE PRESSE INFORMATION REGLEMENTEE CONNAISSANCE PREALABLE Takeda et TiGenix annoncent que le Cx601 (darvadstrocel) a reçu la décision favorable du CHMP dans le traitement des fistules périanales complexes de [...]
Sanofi: FDA lifts clinical hold on fitusiran
15/12/2017
Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) FDA lifts clinical hold on fitusiran Clinical trial dosing to resume around year-end 2017 Paris and Cambridge, Mass. - December 15, 2017 - Sanofi Genzyme , the [...]
Sanofi : La FDA lève la suspension des essais cliniques consacrés au fitusiran
15/12/2017
Communiqué de presse Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) La FDA lève la suspension des essais cliniques consacrés au fitusiran L'administration de ce médicament dans le cadre des essais cliniques qui lui sont [...]
Ohr Pharmaceutical Reports Fiscal Year 2017 Financial Results
15/12/2017
Management to Host a Conference Call and Webcast at 8:30 a.m. Eastern Time Today NEW YORK, Dec. 15, 2017 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (Nasdaq: OHRP ), a clinical-stage pharmaceutical company developing [...]
Aclaris Therapeutics Receives FDA Approval for ESKATA™ (Hydrogen Peroxide) Topical Solution, 40% (w/w) for the Treatment of Raised Seborrheic Keratoses (SKs)
15/12/2017
ESKATA™ is the First and Only FDA-Approved Topical, Non-invasive Treatment for Raised SKs; Management to Hold Conference Call at 8:00 AM ET Today MALVERN, Pa., Dec. 15, 2017 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc [...]

Pages